Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All Videos10 Things That Got Me Through TreatmentCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVCalled to CareEducated Patient Sound BitesExercise of the WeekFrom All AnglesOn Demand: WebinarsShortsText a SurvivorThe Breast Cancer BriefingThe Cancer Search Bar
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gallbladder Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement

Naval Daver, MD

Advertisement

Articles by Naval Daver, MD

MDM2 Inhibitor Shows Promise For Patients With AML

ByNaval Daver, MD
December 23rd 2019

New findings show that a wider study is needed for MDM2 inhibitors in treating patients with AML.

Advertisement

Latest Updated Articles

  • MDM2 Inhibitor Shows Promise For Patients With AML
    MDM2 Inhibitor Shows Promise For Patients With AML

    December 23rd 2019



Advertisement
Advertisement

Trending on CURE

1

Bristol Myers Squibb Reports Positive Results for CAR T-Cell Therapy in Heavily Pretreated Multiple Myeloma

2

Alcohol-Linked Cancer Deaths in the U.S. Doubled Since 1990

3

After Facing Cancer, Two High School Friends Create an App to Help Patients and Caregivers

4

FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer

5

Mariska Hargitay Opens Up About Father's Cancer Journey

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.